Bayer is trading 4.1% up at €50.24 after investors reacted positively to latest quarterly results highlighting improving operating performance and a more constructive margin outlook.
- The move builds on yesterday’s strong session as the market focuses on a strengthening earnings trajectory.
- Improved margins and operational gains have significantly boosted investor confidence in the company’s turnaround prospects.